Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06636175
What this trial is testing

64Cu-LLP2A for Imaging Hematologic Malignancies

Who this might be right for
Multiple MyelomaLow-Grade LymphomaFollicular Lymphoma+4 more
Washington University School of Medicine 42
Early research (Phase 1)Study completedNCT02240719
What this trial is testing

Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Grade 1 Follicular Lymphoma+5 more
University of California, Davis 20
Not applicableStudy completedNCT03508765
What this trial is testing

Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT06430736
What this trial is testing

PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)

Who this might be right for
MyelomaLymphomaLeukemia
Insel Gruppe AG, University Hospital Bern 100
Large-scale testing (Phase 3)WithdrawnNCT01266811
What this trial is testing

Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Centocor, Inc.
Early research (Phase 1)Active Not RecruitingNCT07342114
What this trial is testing

A Clinical Study to Evaluate the Effects of RO7875913 in Healthy Participants and of RO7875913 With Cevostamab in Participnats With With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Healthy VolunteersRelapsed Multiple MyelomaRefractory Multiple Myeloma
Genentech, Inc. 240
Testing effectiveness (Phase 2)Study completedNCT00048412
What this trial is testing

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H

Who this might be right for
Myelodysplastic DisordersLeukemiaMultiple Myeloma+2 more
Baylor College of Medicine 40
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03628612
What this trial is testing

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

Who this might be right for
Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell TherapyMultiple MyelomaDLBCL+2 more
Autolus Limited 500
Early research (Phase 1)Study completedNCT01393964
What this trial is testing

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 35
Not applicableUnknownNCT05536154
What this trial is testing

Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

Who this might be right for
LymphomaMultiple Myeloma
The Affiliated People's Hospital of Ningbo University 68
Testing effectiveness (Phase 2)UnknownNCT03641456
What this trial is testing

VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma

Who this might be right for
MyelomaNewly DiagnosedHigh Risk
Sun Yat-sen University 50
Early research (Phase 1)Study completedNCT05376345
What this trial is testing

BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Shanghai Changzheng Hospital 24
Large-scale testing (Phase 3)Active Not RecruitingNCT00098475
What this trial is testing

Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma

Who this might be right for
DS Stage I Multiple MyelomaDS Stage II Multiple MyelomaDS Stage III Multiple Myeloma
National Cancer Institute (NCI) 452
Testing effectiveness (Phase 2)UnknownNCT03143036
What this trial is testing

Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma

Who this might be right for
Relapse and / or Refractory Myeloma
National University Hospital, Singapore 100
Testing effectiveness (Phase 2)Study completedNCT00718419
What this trial is testing

Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma

Who this might be right for
Waldenstrom's MacroglobulinemiaMultiple Myeloma
Eli Lilly and Company 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT06357975
What this trial is testing

Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Genetic Changes (MATCH - Subprotocol C1)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)WithdrawnNCT03168100
What this trial is testing

2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas
Testing effectiveness (Phase 2)WithdrawnNCT03100877
What this trial is testing

Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma

Who this might be right for
Plasma Cell Leukemia in RemissionPlasma Cell Myeloma
City of Hope Medical Center
Not applicableUnknownNCT05693012
What this trial is testing

Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Qiu Lugui 398
Testing effectiveness (Phase 2)Study completedNCT00083681
What this trial is testing

DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse

Who this might be right for
Multiple Myeloma
University of Arkansas 180
Next Page